Silencing tau to treat early Alzheimer's disease
Nat Med
.
2023 Jun;29(6):1320-1321.
doi: 10.1038/s41591-023-02357-w.
Authors
Peter A Ljubenkov
1
,
Gil D Rabinovici
2
3
Affiliations
1
Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, USA.
2
Memory and Aging Center, Department of Neurology, University of California San Francisco, San Francisco, CA, USA. gil.rabinovici@ucsf.edu.
3
Department of Radiology & Biomedical Imaging, University of California San Francisco, San Francisco, CA, USA. gil.rabinovici@ucsf.edu.
PMID:
37198457
DOI:
10.1038/s41591-023-02357-w
No abstract available
MeSH terms
Alzheimer Disease* / genetics
Alzheimer Disease* / therapy
Amyloid beta-Peptides / genetics
Humans
tau Proteins / genetics
Substances
tau Proteins
Amyloid beta-Peptides